Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000148723 | SCV000852105 | likely benign | Phenylketonuria | 2018-08-10 | reviewed by expert panel | curation | PAH-specific ACMG/AMP criteria applied: BS1: MAF= 0.01815 in 1000G. 2 homozygotes in ExAC, 1 homozygote in 1000G.; BS3_Supporting: Enzyme activity of K274E is indistinguishable from that of the wild-type protein. Detailed kinetic analyses of PAH expressed in E. coli showed that the K274E mutant protein has kinetic properties similar to that of the wild-type protein. (PMID:11461196). In summary this variant meets criteria to be classified as likely benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, BS3_Supporting). |
Counsyl | RCV000148723 | SCV000220150 | likely benign | Phenylketonuria | 2014-03-19 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV000148723 | SCV001014240 | benign | Phenylketonuria | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000148723 | SCV001138800 | benign | Phenylketonuria | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000089112 | SCV005216785 | likely benign | not provided | criteria provided, single submitter | not provided | ||
De |
RCV000089112 | SCV000119719 | not provided | not provided | no assertion provided | not provided | ||
CSER _CC_NCGL, |
RCV000148723 | SCV000190455 | likely benign | Phenylketonuria | 2014-06-01 | no assertion criteria provided | research | |
Natera, |
RCV000148723 | SCV001455413 | benign | Phenylketonuria | 2020-04-17 | no assertion criteria provided | clinical testing |